Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels

Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels

Abstract A hexanucleotide repeat expansion in a noncoding region of C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Reduction of select or total C9orf72 transcript and protein levels is observed in postmortem C9-ALS/FTD tissue, and l...

Full description

Bibliographic Details
Main Authors:	Shangxi Xiao, Paul M. McKeever, Agnes Lau, Janice Robertson
Format:	Article
Language:	English
Published:	BMC 2019-10-01
Series:	Acta Neuropathologica Communications
Subjects:	Amyotrophic lateral sclerosis Frontotemporal dementia C9orf72 PSD-95 GluR1 Rab39b
Online Access:	http://link.springer.com/article/10.1186/s40478-019-0812-5

Similar Items

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
by: Petra Frick, et al.
Published: (2018-08-01)

Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
by: Xiaoqiang Tang, et al.
Published: (2020-06-01)

RNA Misprocessing in C9orf72-Linked Neurodegeneration
by: Holly V. Barker, et al.
Published: (2017-07-01)

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
by: Hannah Rostalski, et al.
Published: (2019-05-01)

A comparative bioinformatic analysis of C9orf72
by: Shalini Iyer, et al.
Published: (2018-02-01)

G‐quadruplex‐binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo
by: Roberto Simone, et al.
Published: (2018-01-01)

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
by: Ileana Lorenzini, et al.
Published: (2023-06-01)

Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
by: Qihui Zhou, et al.
Published: (2020-02-01)

C9ORF72 and the FTD-ALS spectrum: a systematic review of neuroimaging studies
by: Laura de Godoy Rousseff Prado, et al.

Deregulated expression of a longevity gene, Klotho, in the C9orf72 deletion mice with impaired synaptic plasticity and adult hippocampal neurogenesis
by: Wan Yun Ho, et al.
Published: (2020-09-01)

Breakdown of the central synapses in C9orf72-linked ALS/FTD
by: Layla T. Ghaffari, et al.
Published: (2022-09-01)

Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
by: Dennis W. Dickson, et al.
Published: (2019-10-01)

Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS
by: Philip McGoldrick, et al.
Published: (2023-08-01)

The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion
by: Emma M Devenney, et al.
Published: (2017-01-01)

Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD
by: Carina Lehmer, et al.
Published: (2017-07-01)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
by: Elaine Y. Liu, et al.
Published: (2020-08-01)

C9orf72’s interaction with Rab GTPases - modulation of membrane traffic and autophagy
by: Bor Luen Tang
Published: (2016-10-01)

CRISPR interference to evaluate modifiers of C9ORF72-mediated toxicity in FTD
by: Sarah Pickles, et al.
Published: (2023-08-01)

Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72
by: Carl Laflamme, et al.
Published: (2019-10-01)

Young Onset Alzheimer’s Disease Associated with <i>C9ORF72</i> Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association
by: Giulia Vinceti, et al.
Published: (2023-04-01)

Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
by: Jeannie Chew, et al.
Published: (2019-02-01)

Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype
by: Mary Kay Floeter, et al.
Published: (2016-01-01)

C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
by: Maria-Belen Lopez-Herdoiza, et al.
Published: (2023-04-01)

Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients
by: Daniel A. Mordes, et al.
Published: (2018-07-01)

Role of C9orf72 hexanucleotide repeat expansions in ALS/FTD pathogenesis
by: Yanyan Geng, et al.
Published: (2024-01-01)

RNA-mediated toxicity in C9orf72 ALS and FTD
by: Zachary T. McEachin, et al.
Published: (2020-11-01)

C9orf72 gene networks in the human brain correlate with cortical thickness in C9-FTD and implicate vulnerable cell types
by: Iris J. Broce, et al.
Published: (2024-02-01)

Synaptic dysfunction induced by glycine‐alanine dipeptides in C9orf72‐ALS/FTD is rescued by SV2 replenishment
by: Brigid K Jensen, et al.
Published: (2020-05-01)

Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
by: Emiliano Giardina, et al.
Published: (2024-01-01)

Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion
by: Anna Junttila, et al.
Published: (2016-04-01)

<i>C9ORF72</i> Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia
by: Izaro Kortazar-Zubizarreta, et al.
Published: (2023-09-01)

BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci
by: Hannah Rostalski, et al.
Published: (2020-10-01)

New Antibody-Free Mass Spectrometry-Based Quantification Reveals That C9ORF72 Long Protein Isoform Is Reduced in the Frontal Cortex of Hexanucleotide-Repeat Expansion Carriers
by: Arthur Viodé, et al.
Published: (2018-08-01)

Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
by: Mehdi Ghasemi, et al.
Published: (2021-01-01)

Analysis of Heritability Across the Clinical Phenotypes of Frontotemporal Dementia and the Frequency of the C9ORF72 in a Colombian Population
by: Andrea López-Cáceres, et al.
Published: (2021-08-01)

Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD
by: Yuanjing Liu, et al.
Published: (2022-06-01)

Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia
by: Ranjan Batra, et al.
Published: (2017-07-01)

The repeat length of C9orf72 is associated with the survival of amyotrophic lateral sclerosis patients without C9orf72 pathological expansions
by: Lu Tang, et al.
Published: (2022-08-01)

C9orf72 Proteins Regulate Autophagy and Undergo Autophagosomal or Proteasomal Degradation in a Cell Type-Dependent Manner
by: Stina Leskelä, et al.
Published: (2019-10-01)

Metformin ameliorates the mitochondrial damage induced by C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia-related poly-GR
by: FENG Yiyuan, et al.
Published: (2023-07-01)